SGX Market Updates

20 Singapore Index Stocks Most Sought By Institutions in YTD


PUBLISHED ON |

17 February 2021

  • The FTSE ST All Share Index generated a 3.6% total return in the 2021 year-to-date, with net institutional outflows of S$232 million. The 106 stocks include STI constituent stocks, mid-cap and small-cap stocks which include 37 trusts of the REIT Sector.

  • The past 6 weeks have seen similar sector trends within the Index as observed in 2020, with Technology and Consumer Non-Cyclical stocks among the stronger sectors, while the Consumer Cyclical and Real Estate (excluding REITs) sectors have lagged the Index.

  • The 20 stocks with the highest net institutional inflows over the past 6 weeks represent 7 sectors, have averaged 10% total returns over the period, with 8 of the 20 stocks also recipient to the highest net institutional flows proportionate to market value.



The FTSE ST All Share Index is comprised of 106 constituents which includes the 30 stocks of the Straits Times Index and 76 mid-cap to small-cap stocks. Market capitalisation of the stocks range from S$66 billion for DBS Group to S$94 million for mm2 Asia. The Index has generated a 3.3% gain in the 2021 year to 16 February, with dividend distributions, predominately from REITs boosting the total return to 3.6%.



Thomson Medical Group Leads Health Stocks and Index in 2021 Year-To-Date

The past 6 weeks have seen similar sector trends within the FTSE ST All-Share Index as observed in 2020. Technology was the strongest sector of the Index in 2020 and has been the second strongest sector of the Index in the 2021 year to 16 February. The 80% gains of Thomson Medical Group in the 2021 year to 16 February means that the Healthcare Sector, represent by 3 stocks in total, has been the strongest sector of the Index for the 6 weeks period. Thomson Medical Group has also been the strongest constituent of the Index for the period.

On 8 February, Thomson Medical Group reported net profit after tax of S$9.7 million for its 1HFY21 (ended 31 Dec 2020), a reversal from its S$1.0 million loss in 1HFY20 (click here for more). The leading healthcare player in the South-East Asian region with Singapore and Malaysia operations also noted that excluding COVID-19 related grants from the Singapore Government, the Group remained profitable recording a net profit after tax of S$4.5 million.

The Index’s Consumer Non-Cyclical stocks have been the third strongest sector in the 2021 year to 16 February, averaging 11% total returns, following on from averaging 4% declines in 2020. Meanwhile Consumer Cyclicals and Real Estate (excluding REITs) have remained laggard Sectors over the period.



20 Index Stocks Most Sought By Institutions in 2021 Year-To-Date

The 20 stocks with the highest net institutional inflows over the past 6 weeks represent 7 sectors, have averaged 10% total returns over the period, with the median total return at 7%. The 20 stocks include a number of stocks that lagged the FTSE ST All-Share Index in 2020, including Sembcorp Marine, Singapore Press Holdings, Jardine Cycle & Carriage, Singapore Airlines and Dairy Farm International.

While the entire 106 stocks have been recipient to net institutional outflows of S$232 million in the 2021 year to 16 February, the 20 stocks tabled below drew combined inflows of S$630 million. 8 of the 20 stocks were also among the 10 stocks recipient to the highest net institutional flows proportionate to market value, including AEM Holdings, Jardine Cycle & Carriage, UMS Holdings, Sembcorp Marine, Yangzijiang Shipbuilding, Singapore Press Holdings, CapitaLand China Trust and ARA LOGOS Logistics Trust.


Stock SGX
Code
Market
Cap
S$m
Net
Institutional
Flow
(S$M)
Net
Institutional
Flow /
Market Cap
(%)
YTD
Total
Return
%
2020
Total
Return
%
Sector
UOB U11 40,181 124.5 0.31% 6.3 -9.6 Financial Services
OCBC Bank O39 47,602 62.3 0.13% 5.8 -3.6 Financial Services
Wilmar International F34 34,810 61.7 0.18% 18.5 16.7 Consumer Non-Cyclicals
AEM AWX 1,264 49.0 3.88% 33.0 74.6 Technology (Hardware/ Software)
Jardine C&C C07 8612 44.3 0.51% 11.5 -32.0 Consumer Cyclicals
SGX S68 10,734 39.0 0.36% 8.8 8.4 Financial Services
UMS 558 731 36.6 5.01% 26.9 10.5 Technology (Hardware/ Software)
Sembcorp Marine S51 2021 32.5 1.61% 12.6 -83.1 Industrials
DBS D05 66333 29.3 0.04% 3.8 1.7 Financial Services
Yangzijiang Shipbuilding BS6 4041 26.5 0.65% 9.9 -10.8 Industrials
Singapore Airlines C6L 13046 24.2 0.19% 2.8 -32.8 Industrials
Keppel DC REIT AJBU 4753 14.8 0.31% 5.2 38.4 REITs
SPH T39 1942 14.2 0.73% 8.0 -47.2 Consumer Cyclicals
CapitaLand China Trust AU8U 2109 13.5 0.64% 0.4 -7.0 REITs
SATS S58 4625 11.4 0.25% 3.8 -21.3 Industrials
Dairy Farm International D01 7903 11.2 0.14% 6.0 -24.7 Consumer Non-Cyclicals
Venture Corp V03 5910 9.9 0.17% 4.9 25.2 Technology (Hardware/ Software)
Keppel REIT K71U 4040 8.6 0.21% 8.0 -6.3 REITs
ARA LOGOS Logistics Trust K2LU 920 8.5 0.92% 21.4 -7.3 REITs
CapitaLand C31 16254 8.5 0.05% -4.6 -8.9 Real Estate (excl. REITs)
Average 9.7 -6.0
Median 7.1 -7.2

Source: Reuters, Bloomberg, SGX StockFacts (Data as of 16 February 2021)







This article is provided by SGX My Gateway.



SGX My Gateway

SGX's investor education portal with market, product and investment information and events. Sign up now at sgx.com/mygateway to receive our investment updates and economic calendar.

This document is not intended for distribution to, or for use by or to be acted on by any person or entity located in any jurisdiction where such distribution, use or action would be contrary to applicable laws or regulations or would subject Singapore Exchange Limited (“SGX”) to any registration or licensing requirement. This document is not an offer or solicitation to buy or sell, nor financial advice or recommendation for any investment product. This document is for general circulation only. It does not address the specific investment objectives, financial situation or particular needs of any person. Advice should be sought from a financial adviser regarding the suitability of any investment product before investing or adopting any investment strategies. Use of and/or reliance on this document is entirely at the reader’s own risk. Further information on this investment product may be obtained from www.sgx.com. Investment products are subject to significant investment risks, including the possible loss of the principal amount invested. Past performance of investment products is not indicative of their future performance. Examples provided are for illustrative purposes only. While each of SGX and its affiliates (collectively, the SGX Group Companies) have taken reasonable care to ensure the accuracy and completeness of the information provided, each of the SGX Group Companies disclaims any and all guarantees, representations and warranties, expressed or implied, in relation to this document and shall not be responsible or liable (whether under contract, tort (including negligence) or otherwise) for any loss or damage of any kind (whether direct, indirect or consequential losses or other economic loss of any kind, including without limitation loss of profit, loss of reputation and loss of opportunity) suffered or incurred by any person due to any omission, error, inaccuracy, incompleteness, or otherwise, any reliance on such information, or arising from and/or in connection with this document. The information in this document may have been obtained via third party sources and which have not been independently verified by any SGX Group Company. No SGX Group Company endorses or shall be liable for the content of information provided by third parties. The SGX Group Companies may deal in investment products in the usual course of their business, and may be on the opposite side of any trades. SGX is an exempt financial adviser under the Financial Advisers Act (Cap. 110) of Singapore. The information in this document is subject to change without notice. This document shall not be reproduced, republished, uploaded, linked, posted, transmitted, adapted, copied, translated, modified, edited or otherwise displayed or distributed in any manner without SGX’s prior written consent.












Stock / REIT Search

Advertisement

Advertisement